Anthranilic acid based CCK1 antagonists: the 2-indole moiety may represent a “needle” according to the recent homonymous concept

Add time:08/03/2019    Source:sciencedirect.com

Recently we described an innovative class of non-peptide CCK1 antagonists keeping appropriate pharmacophoric groups on the anthranilic acid employed as a molecular scaffold. The lead compound obtained, VL-0395, characterized by the presence of Phe and the 2-indole moiety at the C- and N-termini of anthranilic acid, respectively, is endowed with submicromolar affinity towards CCK1 receptors. Thus, we have prepared and tested on CCK receptors a library of VL-0395 analogues in order to investigate the precise topological and essential key interactions of the 2-indole group of the lead with the CCK1 receptor. The obtained results confirm that this group establishes very specific interactions with this receptor sub-site and may be viewed as a “needle” group.

We also recommend Trading Suppliers and Manufacturers of (4-CHLORO-BENZOYLAMINO)-ACETIC ACID (cas 13450-77-6). Pls Click Website Link as below: cas 13450-77-6 suppliers

Prev:Liquid chromatography–tandem mass spectrometry method for the analysis of N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine, a biocidal disinfectant, in dairy products
Next:2H-Pyran-2-ones as synthons for (E)-α,β-didehydroamino acid derivatives)